Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Copenhagen – page 14

771 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
771
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

771 trials in Copenhagen

Open in trial search

Chronic lymphocytic leukaemia+3

Recruiting

Study on the Safety and Effectiveness of AZD0486 Alone or with Other Drugs for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, or Large B-Cell Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Endometrial cancer+18

Recruiting

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bay 2927088
  • Sponsor:Bayer AG

Tubulointerstitial nephritis

Recruiting

Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Region Midtjylland

Chronic graft versus host disease

Recruiting

Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Incyte Corp.

Malignant melanoma

Recruiting

Study on [68Ga]Ga-FAPI-46 and Fludeoxyglucose (18F) PET/CT Imaging for Evaluating Treatment Response in Patients with Advanced Malignant Melanoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Region Hovedstaden

Staphylococcal bacteraemia

Recruiting

Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Hvidovre Hospital

Diffuse large B-cell lymphoma refractory+2

Recruiting

Study on the Effectiveness and Safety of AZD0486 for Adults with Relapsed or Refractory Non-Hodgkin Lymphoma

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
  • Sponsor:AstraZeneca AB

Acute myocardial infarction

Recruiting

Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Midtjylland

Cancer fatigue

Recruiting

Study on Methylphenidate for Reducing Fatigue in Childhood Brain Tumor Survivors

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:METHYLPHENIDATE
  • Sponsor:Odense University Hospital

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:Takeda Development Center Americas Inc.

Study of FG001 for Detecting Meningioma or Low-Grade Glioma in Patients Undergoing Neurosurgery

Recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:FG001
  • Sponsor:Copenhagen University Hospital

Hip fracture

Recruiting

Study on the Effects of Ferric Derisomaltose on Mobility in Elderly Patients After Hip Fracture Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Respiratory & Pulmonary Studies

Clinical research focusing on chronic obstructive pulmonary disease (COPD) and nasal conditions, evaluating new therapeutic approaches for respiratory disorders.

  • COPD Treatment Evaluation
  • Chronic Rhinosinusitis Management
  • Nasal Polyps Research

Studies aim to improve treatment outcomes and quality of life for patients with respiratory conditions.

02 Metabolic & Endocrine Research

Investigations into early-onset obesity and related metabolic disorders, with emphasis on innovative treatment approaches.

  • Obesity Management
  • Metabolic Disease Treatments
  • Clinical Weight Management

Focus on developing effective interventions for weight-related health conditions.

03 Mental Health Studies

Research addressing postpartum depression and psychiatric disorders, including innovative hormone therapy approaches and sleep disorders.

  • Maternal Mental Health
  • Insomnia Treatment
  • Depression Prevention

Emphasis on developing targeted treatments for specific mental health conditions.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.